ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05220	Chronic myeloid leukemia	4/24	85/7206	0.000160044492732
ko05161	Hepatitis B	5/24	173/7206	0.000220873411933
ko04350	TGF-beta signaling pathway	4/24	103/7206	0.000335731867204
ko05200	Pathways in cancer	7/24	492/7206	0.00082530172146
ko05212	Pancreatic cancer	3/24	83/7206	0.00250465584631
ko05206	MicroRNAs in cancer	4/24	177/7206	0.00254483079248
ko05167	Kaposi's sarcoma-associated herpesvirus infection	4/24	191/7206	0.00335297811444
ko05211	Renal cell carcinoma	3/24	96/7206	0.0037859805035
ko05169	Epstein-Barr virus infection	4/24	206/7206	0.0043978400478
ko04520	Adherens junction	3/24	103/7206	0.00461515401565
ko05215	Prostate cancer	3/24	111/7206	0.00568849257059
ko04066	HIF-1 signaling pathway	3/24	123/7206	0.00756053269134
ko04630	Jak-STAT signaling pathway	3/24	132/7206	0.00917868600653
ko04919	Thyroid hormone signaling pathway	3/24	143/7206	0.0114140455924
ko04110	Cell cycle	3/24	145/7206	0.0118514953101
ko05203	Viral carcinogenesis	4/24	277/7206	0.0123641660117
ko04024	cAMP signaling pathway	4/24	279/7206	0.0126704603473
ko05166	HTLV-I infection	4/24	292/7206	0.0147818270356
ko05164	Influenza A	3/24	167/7206	0.0173079052818
ko04068	FoxO signaling pathway	3/24	167/7206	0.0173079052818
ko04330	Notch signaling pathway	2/24	62/7206	0.0178008375169
ko04910	Insulin signaling pathway	3/24	172/7206	0.0187151152812
ko04218	Cellular senescence	3/24	177/7206	0.0201849374254
ko05168	Herpes simplex infection	3/24	182/7206	0.0217175925665
ko05152	Tuberculosis	3/24	187/7206	0.0233132430068
ko05131	Shigellosis	2/24	82/7206	0.0300269300527
ko05016	Huntington's disease	3/24	215/7206	0.0334151496754
ko04917	Prolactin signaling pathway	2/24	87/7206	0.0334859228218
ko05222	Small cell lung cancer	2/24	89/7206	0.0349117238807
ko05132	Salmonella infection	2/24	98/7206	0.0416147291125
ko04720	Long-term potentiation	2/24	99/7206	0.0423876301852
ko04659	Th17 cell differentiation	2/24	106/7206	0.0479487750659